NovaBay Pharmaceuticals Files 2025 Proxy Statement
Ticker: NBY · Form: DEF 14A · Filed: Mar 19, 2025 · CIK: 1389545
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
NovaBay Proxy Filed: Vote on directors & auditors for April 16 meeting.
AI Summary
NovaBay Pharmaceuticals, Inc. filed its definitive proxy statement on March 19, 2025, for its annual meeting of stockholders scheduled for April 16, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of the independent registered public accounting firm.
Why It Matters
This filing provides shareholders with crucial information about the company's leadership, executive pay, and upcoming voting matters, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently present new financial risks.
Key Players & Entities
- NovaBay Pharmaceuticals, Inc. (company) — Registrant
- 0001389545 (company) — Central Index Key
- 2000 Powell Street, Suite 1150 (location) — Business Address
- Emeryville, California (location) — Business Address City/State
- April 16, 2025 (date) — Annual Meeting Date
- March 19, 2025 (date) — Filing Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing details on matters to be voted upon.
When is the NovaBay Pharmaceuticals annual meeting scheduled?
The annual meeting of stockholders for NovaBay Pharmaceuticals is scheduled for April 16, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on March 19, 2025.
What is the company's primary business classification?
NovaBay Pharmaceuticals, Inc. is classified under Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.
Where is NovaBay Pharmaceuticals, Inc. headquartered?
NovaBay Pharmaceuticals, Inc. is located at 2000 Powell Street, Suite 1150, Emeryville, California.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 19, 2025 regarding NovaBay Pharmaceuticals, Inc. (NBY).